2-(1-(3-(9H-carbazol-4-yloxy)-2-hydroxypropyl)piperidin-4-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione

ID: ALA1083363

PubChem CID: 46889809

Max Phase: Preclinical

Molecular Formula: C32H29N3O4

Molecular Weight: 519.60

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1c2cccc3cccc(c23)C(=O)N1C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1

Standard InChI:  InChI=1S/C32H29N3O4/c36-22(19-39-28-13-5-12-27-30(28)23-8-1-2-11-26(23)33-27)18-34-16-14-21(15-17-34)35-31(37)24-9-3-6-20-7-4-10-25(29(20)24)32(35)38/h1-13,21-22,33,36H,14-19H2

Standard InChI Key:  CFGRSSGFUGIJMC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 45  0  0  0  0  0  0  0  0999 V2000
   18.2119  -11.9796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9367  -11.5855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.6417  -12.0236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9573  -10.7673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3620  -11.6299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0590  -12.0628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7839  -11.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8075  -10.8499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6861  -10.3752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3862  -10.8089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1097  -10.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1344   -9.5965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4295   -9.1645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7088   -9.5564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6187  -12.8483    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2544  -10.3353    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4997  -14.4735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2162  -14.0602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2133  -13.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9262  -12.8145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6422  -13.2243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3552  -12.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0712  -13.2189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3520  -11.9841    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7841  -12.8037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5000  -13.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2108  -12.8050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4961  -11.5676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7790  -11.9810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7849  -14.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7778  -13.2306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4938  -12.8181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1643  -12.6772    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5009  -11.9225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3196  -12.0096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8024  -11.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4677  -10.5931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6455  -10.5097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1663  -11.1752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  8 11  2  0
 18 19  1  0
 19 32  2  0
  3  5  1  0
 19 20  1  0
  9  4  1  0
 20 21  1  0
  9 10  1  0
 21 22  1  0
  2  3  1  0
 22 23  1  0
 10 11  1  0
 22 24  1  0
 10  5  2  0
 23 25  1  0
 25 26  1  0
 11 12  1  0
 12 13  2  0
  5  6  1  0
 25 29  1  0
 26 27  1  0
 27  1  1  0
  1 28  1  0
 28 29  1  0
 30 31  2  0
 13 14  1  0
 31 32  1  0
 14  9  2  0
  1  2  1  0
  3 15  2  0
 32 35  1  0
 34 33  1  0
 33 31  1  0
  6  7  2  0
  4 16  2  0
 34 35  2  0
  2  4  1  0
 35 36  1  0
 30 17  1  0
 36 37  2  0
  7  8  1  0
 37 38  1  0
 17 18  2  0
 38 39  2  0
 39 34  1  0
M  END

Associated Targets(Human)

ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.60Molecular Weight (Monoisotopic): 519.2158AlogP: 4.97#Rotatable Bonds: 6
Polar Surface Area: 85.87Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.03CX LogP: 4.06CX LogD: 3.34
Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.31Np Likeness Score: -0.47

References

1. Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P..  (2010)  A vHTS approach for the identification of beta-adrenoceptor ligands.,  20  (11): [PMID:20434333] [10.1016/j.bmcl.2010.04.009]

Source